Home Tags HusCompagniet
Global private equity giant KKR has hired former Matches Fashion CEO Ajay Kavan as a senior advisor in Europe.
Specialty materials, chemicals and pharma-focused investment house SK Capital Partners has agreed to sell Niacet to food major Kerry Group in a deal worth more than $1bn.
The Covid-19 crisis has pushed what was already a healthy pharmaceutical investment market into overdrive, especially for tech and software-related deals. Fresh from his firm's buyout of clinical trial finance software provider Greenphire, Thoma Bravo partner Hudson Smith explained to AltAssets how to navigate the sector's high prices and where firms need to be aiming to get the best returns.
Intera Partners has hit a €335m hard cap close for its latest fund targeting the capital gap in Finland's lower mid-market.
BDC spinout Amplitude Venture Capital has hit its C$200m target for the final close of its debut fund targeting Canadian healthcare companies.
Sector specialist private equity player Encore Consumer Capital has promoted Kate Wallman to managing director after five years with the firm.
Private equity major EQT has agreed a $9.6bn sale of vaccine DNA and mRNA supplier Aldevron to Danaher Corp, just two years after buying into the business.
Distressed and credit-intensive asset-focused CarVal Investors has hauled in $3.6bn for its latest Credit Value Fund, exceeding its hard cap by 20%.
HQ Capital has beaten its target for its second co-investment fundraise by reaching a $210m final close.
The biggest investment ever made in a private database business has seen Neo4j’s valuation soar to more than $2bn.